SCHEMBL16793236

SCHEMBL16793236

Cn1ccc(-c2ccccc2)c(CN)c1=O

nearest known ligand 0.54

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ DPP4 P27487 7/20 0.49
▸ DPP8 Q6V1X1 1/20 0.49
▸ BRD4 O60885 5/20 0.45
▸ MAPK1 P28482 1/20 0.40
▸ GRM2 Q14416 1/20 0.39
▸ ATAD2 Q6PL18 1/20 0.36
▸ LIPG Q9Y5X9 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28510085 0.80 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2BRD4MAPK1
SCHEMBL18918395 0.80 KDM4E (0.50) KDM4EALDH1A1SMN1; SMN2BRD4MAPK1
SCHEMBL28051853 0.73 IDH1 (0.38) KDM4EALDH1A1SMN1; SMN2DPP4DPP8
SCHEMBL11575773 0.71 KDM4E (0.54) KDM4EALDH1A1SMN1; SMN2BRD4MAPK1
SCHEMBL16793353 0.70 ALDH1A1 (1.00) KDM4EALDH1A1SMN1; SMN2BRD4MAPK1
SCHEMBL27670029 0.69 DPP4 (0.60) ALDH1A1DPP4DPP8MAPK1HSD17B10
SCHEMBL15732165 0.69 ALDH1A1 (0.47) KDM4EALDH1A1SMN1; SMN2DPP4DPP8
SCHEMBL18136496 0.68 BRD4 (0.49) KDM4EALDH1A1SMN1; SMN2DPP4BRD4
Hydrogen Sulfide SCHEMBL27639876 0.68 DPP4 (0.58) ALDH1A1DPP4DPP8MAPK1HSD17B10
SCHEMBL15717101 0.67 ALDH1A1 (0.46) KDM4EALDH1A1SMN1; SMN2DPP4BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015089137-A1 ACYLGUANIDINES AS TRYPTOPHAN HYDROXYLASE INHIBITORS KAROS PHARMACEUTICALS, INC. (US) 2015-06-18 — — WO disclosed
WO-2015089137-A1 ACYLGUANIDINES AS TRYPTOPHAN HYDROXYLASE INHIBITORS KAROS PHARMACEUTICALS, INC. (US) 2015-06-18 — — WO disclosed
Send feedback